Rumored Buzz on Healthcare News
FTC sues important pharmacy profit administrators around insulin costs The company introduced action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list cost of lifetime-preserving insulin medications.Elevance lowers guidance on ‘unprece